| Dr Marianne S Rosen, MD | |
|
2601 Compass Rd Ste 125, Glenview, IL 60026 | |
| (847) 843-3376 | |
| Not Available |
| Full Name | Dr Marianne S Rosen |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 25 Years |
| Location | 2601 Compass Rd Ste 125, Glenview, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083670111 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Forefront Dermatology | 3779471701 | 474 |
News Archive
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.
Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 9 days ago
| Entity Name | Scott D Glazer Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215151857 PECOS PAC ID: 5890711642 Enrollment ID: O20051020000578 |
News Archive
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.
Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 9 days ago
| Entity Name | Brodsky Dermatology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962553867 PECOS PAC ID: 0941302863 Enrollment ID: O20070223000470 |
News Archive
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.
Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 9 days ago
| Entity Name | Forefront Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053783308 PECOS PAC ID: 3779471701 Enrollment ID: O20151130001424 |
News Archive
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.
Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marianne S Rosen, MD 801 York St, Manitowoc, WI 54220-4630 Ph: (920) 663-9008 | Dr Marianne S Rosen, MD 2601 Compass Rd Ste 125, Glenview, IL 60026 Ph: (847) 843-3376 |
News Archive
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.
Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.
A team of researchers from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla have developed a safe strategy for reprogramming cells to a pluripotent state without use of viral vectors or genomic insertions. Their studies reveal that these induced pluripotent stem cells (iPSCs) are very similar to human embryonic stem cells, yet maintain a "transcriptional signature." In essence, these cells retain some memory of the donor cells they once were.
› Verified 9 days ago
Betty Kong, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2701 Patriot Blvd, Glenview, IL 60026 Phone: 847-666-5664 | |
Dr. Elizabeth Marie Damstetter, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2350 Ravine Way Ste 400, Glenview, IL 60025 Phone: 847-400-2542 Fax: 847-221-6935 | |
Dr. Benjamin R Marks, M.D./PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2701 Patriot Blvd, Suite 250, Glenview, IL 60026 Phone: 847-724-4536 | |
Lady C Dy, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1452 Waukegan Rd, Glenview, IL 60025 Phone: 847-832-1185 | |
Dr. Jessica Lane Borowicz, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2601 Compass Rd, Ste 125, Glenview, IL 60026 Phone: 847-843-3376 | |
Dr. Renata Trela Brindise, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2601 Compass Rd Ste 125, Glenview, IL 60026 Phone: 847-843-3376 Fax: 847-998-8631 |